Global Hemostasis Diagnostic Devices And Equipment Market Insights 2024, Forecast To 2033
12 Jan, 2024
The hemostasis diagnostic devices and equipment market size has demonstrated rapid growth, increasing from $5.48 billion in 2023 to $6.18 billion in 2024, with a 12.8% CAGR. Historical growth is attributed to clinical diagnostics, surgical procedures, anticoagulant therapy monitoring, and hemophilia and bleeding disorders. Anticipating rapid growth, the market is projected to reach $9.85 billion in 2028, showcasing a 12.3% CAGR. Future growth drivers include an aging population, cardiovascular and chronic diseases, personalized medicine, and rising surgical procedures. Key trends encompass point-of-care testing, automation and robotics, biomarker discovery, and telemedicine and remote monitoring.
Global Hemostasis Diagnostic Devices And Equipment Market Key Driver
The surge in surgeries for cardiovascular diseases (CVD) using hemostasis devices results from an aging population prone to disease. Hemostasis devices efficiently accelerate blood clotting during surgeries, addressing the higher incidence of CVD in the elderly.
Get A Free Sample Of The Global Hemostasis Diagnostic Devices And Equipment Market ReportGlobal Hemostasis Diagnostic Devices And Equipment Market Segments
The hemostasis diagnostic devices and equipment market covered in this report is segmented –
1)By Product: Analyzers, Coagulation Instrument, Other Hemostasis Instruments, Reagents and Kits
2)By Device Technology: Automated, Semi-Automated, Manual
3)By End User: Hospitals, Clinics, Independent Diagnostic, Laboratories, Other End Users
By Geography: The regions covered in the hemostasis diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions
North America was the largest region in the global hemostasis diagnostic devices and equipment market in 2023. Asia-Pacific was the second-largest region in the hemostasis diagnostic devices and equipment market. The regions covered in the hemostasis diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Major Hemostasis Diagnostic Devices And Equipment Industry Players
C. R. Bard Inc., Baxter International Inc., Pfizer Inc., Johnson & Johnson, Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Chrono-Log Corporation, CSL Behring LLC, F. Hoffmann-La Roche Ltd., Grifols S.A., HemCon Medical Technologies Inc., Integra Life Sciences Corporation, Medtronic plc, Siemens AG, Thermo Fisher Scientific Inc., Trinity Biotech plc., Ethicon Inc., Boston Scientific Corporation, Olympus Corporation, Cook Group Inc., Halyard Health, Medline Industries Inc., ConMed Corporation, Moog Inc., Argon Medical Devices Inc., B. Braun Interventional Systems Inc., Bio-Rad Laboratories Inc., CareFusion Corporation, Danaher Corporation, DemeTECH Corporation, Diagnostica Stago SAS, Dolphin Sutures, EndoEvolution LLC, Haemonetics Corporation, Internacional Farmacéutica S.A. de C.V., Merit Medical Systems Inc., Quidelortho Corp, STAGO, Stryker Corporation
Get The Full Global Hemostasis Diagnostic Devices And Equipment Market Report
Hemostasis Diagnostic Devices And Equipment Market Overview
Hemostasis is the process of slowing and stopping the blood flow to initiate wound healing after a vascular injury. With the help of hemostasis diagnostic devices, the cause of bleeding during surgery can be predicted by identifying any hemostatic defects in patients.
Hemostasis Diagnostic Devices And Equipment Global Market Report 2023 provides data on the global hemostasis diagnostic devices and equipment market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The hemostasis diagnostic devices and equipment market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.